These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6810166)

  • 1. Hypersensitivity of ataxia telangiectasia skin fibroblasts to DNA alkylating agents.
    Barfknecht TR; Little JB
    Mutat Res; 1982 Jun; 94(2):369-82. PubMed ID: 6810166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal sensitivity of skin fibroblasts from familial polyposis patients to DNA alkylating agents.
    Barfknecht TR; Little JB
    Cancer Res; 1982 Apr; 42(4):1249-54. PubMed ID: 6800649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of hereditary retinoblastoma human skin fibroblasts after treatment with DNA-damaging chemicals.
    Barfknecht TR; Little JB
    Mutat Res; 1982 Sep; 105(3):189-94. PubMed ID: 6815522
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypersensitivity to cell killing and faulty repair of 1-beta-D-arabinofuranosylcytosine-detectable sites in human (ataxia-telangiectasia) fibroblasts treated with 4-nitroquinoline 1-oxide.
    Mirzayans R; Smith BP; Paterson MC
    Cancer Res; 1989 Oct; 49(20):5523-9. PubMed ID: 2507129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of BHK cells sensitive to ionizing radiation and alkylating agents.
    Evans HH; Horng MF; Weber MC; Glazier KG
    Radiat Res; 1984 Jul; 99(1):202-10. PubMed ID: 6739724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenesis, by methylating and ethylating agents, in mutH, mutL, mutS, and uvrD mutants of Salmonella typhimurium LT2.
    Shanabruch WG; Rein RP; Behlau I; Walker GC
    J Bacteriol; 1983 Jan; 153(1):33-44. PubMed ID: 6401281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutant of mouse lymphoma cells sensitive to alkylating agents and caffeine.
    Shiomi T; Hieda-Shiomi N; Sato K
    Mutat Res; 1982 Jan; 103(1):61-9. PubMed ID: 7057785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The response of a variety of human fibroblast cell strains to the lethal effects of alkylating agents.
    Teo IA; Arlett CF
    Carcinogenesis; 1982; 3(1):33-7. PubMed ID: 7067035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased DNA repair synthesis and defective colony-forming ability of ataxia telangiectasia fibroblast cell strains treated with N-methyl-N'-nitro-N-nitrosoguanidine.
    Scudiero DA
    Cancer Res; 1980 Apr; 40(4):984-90. PubMed ID: 7357564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular hypersensitivity to neocarzinostatin in ataxia-telangiectasia skin fibroblasts.
    Shiloh Y; Tabor E; Becker Y
    Cancer Res; 1982 Jun; 42(6):2247-9. PubMed ID: 6210429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal regulation of DNA replication and increased lethality in ataxia telangiectasia cells exposed to carcinogenic agents.
    Jaspers NG; de Wit J; Regulski MR; Bootsma D
    Cancer Res; 1982 Jan; 42(1):335-41. PubMed ID: 6172195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alkylating agent hypersensitivity in poly(adenosine diphosphate-ribose) polymerase deficient cell lines.
    Chatterjee S; Cheng MF; Berger SJ; Berger NA
    Cancer Commun; 1991 Mar; 3(3):71-5. PubMed ID: 1900426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity and mutagenicity of alkylating agents in cultured mammalian cells (CHO/HGPRT system): mutagen treatment in the presence or absence of serum.
    O'Neill JP; Schenley RL; Hsie AW
    Mutat Res; 1979 Dec; 63(2):381-5. PubMed ID: 522878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The O6-methylguanine-DNA-methyltransferase activity of rat hepatoma cells is increased after a single exposure to alkylating agents.
    Frosina G; Laval F
    Carcinogenesis; 1987 Jan; 8(1):91-5. PubMed ID: 3802398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced bioreduction of 4-nitroquinoline 1-oxide by cultured ataxia telangiectasia cells.
    Mirzayans R; Sabour M; Paterson MC
    Carcinogenesis; 1988 Sep; 9(9):1711-5. PubMed ID: 3136948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escherichia coli gene that controls sensitivity to alkylating agents.
    Yamamoto Y; Katsuki M; Sekiguchi M; Otsuji N
    J Bacteriol; 1978 Jul; 135(1):144-52. PubMed ID: 353028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with tuberous sclerosis have fibroblasts with normal limits for growth characteristics and sensitivities to DNA alkylating agents.
    Ohno K; Takeshita K
    Jinrui Idengaku Zasshi; 1984 Sep; 29(3):359-69. PubMed ID: 6442744
    [No Abstract]   [Full Text] [Related]  

  • 18. DNA repair deficiency for alkylation damage in cells from Alzheimer's disease patients.
    Bradley WG; Polinsky RJ; Pendlebury WW; Jones SK; Nee LE; Bartlett JD; Hartshorn JN; Tandan R; Sweet L; Magin GK
    Prog Clin Biol Res; 1989; 317():715-32. PubMed ID: 2602434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA synthesis, mutagenesis, DNA damage, and cytotoxicity in cultured mammalian cells treated with alkylating agents.
    Peterson AR
    Cancer Res; 1980 Mar; 40(3):682-8. PubMed ID: 7471086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of O6-methylguanine repair in human normal and ataxia telangiectasia cell lines and correlation of repair capacity with cellular sensitivity to methylating agents.
    Shiloh Y; Becker Y
    Cancer Res; 1981 Dec; 41(12 Pt 1):5114-20. PubMed ID: 7307010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.